Long-term cognitive impairments in adult rats treated neonatally with β-N-methylamino-L-Alanine

Toxicological Sciences

Volumn 112, Issue 1, 2009, Pages 185-195

  Karlsson, Oskar ^a   Roman, Erika ^a   Brittebo, Eva B ^a  

^a UPPSALA UNIVERSITY   (Sweden)

Author keywords

ALS PDC; Behavior; Brain growth spurt; Cyanobacteria; Developmental neurotoxicity; Multivariate concentric square field

Indexed keywords

2 AMINO 3 METHYLAMINOPROPIONIC ACID; CORTICOSTERONE;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BODY WEIGHT; BRAIN FUNCTION; COGNITIVE DEFECT; CONTROLLED STUDY; CORTICOSTERONE BLOOD LEVEL; FEMALE; HYPOPHYSIS ADRENAL SYSTEM; HYPOTHALAMUS HYPOPHYSIS SYSTEM; LEARNING; MAZE TEST; MOTOR PERFORMANCE; NEUROTOXICITY; NEWBORN; NONHUMAN; OPEN FIELD TEST; PERINATAL PERIOD; RAT; SPATIAL MEMORY; TREATMENT DURATION;

AGING; AMINO ACIDS, DIAMINO; ANIMALS; ANIMALS, NEWBORN; BEHAVIOR, ANIMAL; COGNITION DISORDERS; CORTICOSTERONE; EXCITATORY AMINO ACID AGONISTS; FEMALE; PREGNANCY; RATS; RATS, WISTAR;

ANIMALIA; CHLOROPHYTA; CYANOBACTERIA; MUS; RATTUS;

EID: 71049122269     PISSN: 10966080     EISSN: 10960929     Source Type: Journal    
DOI: 10.1093/toxsci/kfp196     Document Type: Article

References (54)

1. Abdulla, E. M., and Campbell, I. C. (1993). Use of neurite outgrowth as an in vitro method of assessing neurotoxicity. Ann. N. Y. Acad. Sci. 679, 276-279.
2. Andersen, S. L. (2003). Trajectories of brain development: Point of vulnerability or window of opportunity? Neurosci. Biobehav. Rev. 27, 3-18.
3. Banack, S. A., and Cox, P. A. (2003). Biomagnification of cycad neurotoxins in flying foxes: Implications for ALS-PDC in Guam. Neurology 61, 387-389.
4. Banack, S. A., Johnson, H. E., Cheng, R., and Cox, P. A. (2007). Production of the neurotoxin BMAA by a marine cyanobacterium. Mar. Drugs 5, 180-196.
5. Bayer, S. A., Altman, J., Russo, R. J., and Zhang, X. (1993). Timetables of neurogenesis in the human brain based on experimentally determined patterns in the rat. Neurotoxicology 14, 83-144.
6. Buenz, E. J., and Howe, C. L. (2007). Beta-methylamino-alanine (BMAA) injures hippocampal neurons in vivo. Neurotoxicology 28, 702-704.
7. Copani, A., Canonico, P. L., Catania, M. V., Aronica, E., Bruno, V., Ratti, E., van Amsterdam, F. T., Gaviraghi, G., and Nicoletti, F. (1991). Interaction between beta-N-methylamino-L-alanine and excitatory amino acid receptors in brain slices and neuronal cultures. Brain Res. 558, 79-86.
8. Cox, P. A., Banack, S. A., Murch, S. J., Rasmussen, U., Tien, G., Bidigare, R. R., Metcalf, J. S., Morrison, L. F., Codd, G. A., and Bergman, B. (2005). Diverse taxa of cyanobacteria produce beta-N-methylamino-L-alanine, a neurotoxic amino acid. Proc. Natl Acad. Sci. U.S.A. 102, 5074-5078.
9. Cruz-Aguado, R., Winkler, D., and Shaw, C. A. (2006). Lack of behavioral and neuropathological effects of dietary beta-methylamino-L-alanine (BMAA) in mice. Pharmacol. Biochem. Behav. 84, 294-299.
10. Davison, A. N., and Dobbing, J. (1968). In The developing brain and vulnerable periods in developing brain, pp. 253-316. Blackwell scientific publications, Oxford.
11. Dawson, R., Jr., Marschall, E. G., Chan, K. C., Millard, W. J., Eppler, B., and Patterson, T. A. (1998). Neurochemical and neurobehavioral effects of neonatal administration of beta-N-methylamino-L-alanine and 3,3′-iminodipropionitrile. Neurotoxicol. Teratol. 20, 181-192.
12. de Kloet, E. R., de Jong, I. E., and Oitzl, M. S. (2008). Neuropharmacology of glucocorticoids: Focus on emotion, cognition and cocaine. Eur. J. Pharmacol. 585, 473-482.
13. Dobbing, J., and Sands, J. (1979). Comparative aspects of the brain growth spurt. Early Hum. Dev. 3, 79-83.
14. Ehman, K. D., and Moser, V. C. (2006). Evaluation of cognitive function in weanling rats: A review of methods suitable for chemical screening. Neurotoxicol. Teratol. 28, 144-161.
15. Eriksson, L., Johansson, E., Kettaneh-Wold, N., Trygg, J., Wikström, C., and Wold, S. (2006). In Multi-and Megavariate Data Analysis, 2nd ed. Umetrics AB, Umeao̊, Sweden.
16. Eriksson, P. (1997). Developmental neurotoxicity of environmental agents in the neonate. Neurotoxicology 18, 719-726.
17. Eriksson, P., Ankarberg, E., and Fredriksson, A. (2000). Exposure to nicotine during a defined period in neonatal life induces permanent changes in brain nicotinic receptors and in behaviour of adult mice. Brain Res. 853, 41-48.
18. Esterhuizen, M., and Downing, T. G. (2008). beta-N-methylamino-l-alanine (BMAA) in novel South African cyanobacterial isolates. Ecotoxicol. Environ. Saf. 71, 309-313.
19. Falconer, I. R., Choice, A., and Hosja, W. (1992). Toxicity of edible mussels (Mytilus edulis) growing naturally in an estuary during waterbloom of the blue-green alga Nodularia spumigena. Environ. Toxicol. Water Qual. 7, 119-123.
20. Handelmann, G. E., and Olton, D. S. (1981). Spatial memory following damage to hippocampal CA3 pyramidal cells with kainic acid: Impairment and recovery with preoperative training. Brain Res. 217, 41-58.
21. Hlinak, Z., Gandalovicova, D., and Krejci, I. (2005). Behavioral deficits in adult rats treated neonatally with glutamate. Neurotoxicol. Teratol. 27, 465-473.
22. Hodges, H. (1996). Maze procedures: The radial-arm and water maze compared. Brain Res. Cogn. Brain Res. 3, 167-181.
23. Hogg, S. (1996). A review of the validity and variability of the elevated plusmaze as an animal model of anxiety. Pharmacol. Biochem. Behav. 54, 21-30.
24. Holmes, A., Parmigiani, S., Ferrari, P. F., Palanza, P., and Rodgers, R. J. (2000). Behavioral profile of wild mice in the elevated plus-maze test for anxiety. Physiol. Behav. 71, 509-516.
25. Jacobson, L., and Sapolsky, R. (1991). The role of the hippocampus in feedback regulation of the hypothalamic-pituitary-adrenocortical axis. Endocr. Rev. 12, 118-134.
26. Karlsson, O., Berg, C., Brittebo, E. B., and Lindquist, N. G. (2009). Retention of the cyanobacterial neurotoxin beta-N-methylamino-l-alanine in melanin and neuromelanin-containing cells - a possible link between Parkinson-dementia complex and pigmentary retinopathy. Pigment Cell Melanoma Res. 22, 120-130.
27. Karlsson, O., Lindquist, N. G., Brittebo, E. B., and Roman, E. (2009). Selective brain uptake and behavioral effects of the cyanobacterial toxin BMAA (beta-N-methylamino-l-alanine) following neonatal administration to rodents. Toxicol. Sci. 109, 286-295.
28. Kent, S., Kernahan, S. D., and Levine, S. (1996). Effects of excitatory amino acids on the hypothalamic-pituitary-adrenal axis of the neonatal rat. Brain Res. Dev. Brain Res. 94, 1-13.
29. Lister, R. G. (1990). Ethologically-based animal models of anxiety disorders. Pharmacol. Ther. 46, 321-340.
30. Lobner, D., Piana, P. M., Salous, A. K., and Peoples, R. W. (2007). Beta-N-methylamino-L-alanine enhances neurotoxicity through multiple mechanisms. Neurobiol. Dis. 25, 360-366.
31. Metcalf, J. S., Banack, S. A., Lindsay, J., Morrison, L. F., Cox, P. A., and Codd, G. A. (2008). Co-occurrence of beta-N-methylamino-L-alanine, a neurotoxic amino acid with other cyanobacterial toxins in British waterbodies, 1990-2004. Environ. Microbiol. 10, 702-708.
32. Meyerson, B. J., Augustsson, H., Berg, M., and Roman, E. (2006). The concentric square field: A multivariate test arena for analysis of explorative strategies. Behav. Brain Res. 168, 100-113.
33. Montine, T. J., Li, K., Perl, D. P., and Galasko, D. (2005). Lack of beta-methylamino-l-alanine in brain from controls, AD, or Chamorros with PDC. Neurology 65, 768-769.
34. Murch, S. J., Cox, P. A., and Banack, S. A. (2004). A mechanism for slow release of biomagnified cyanobacterial neurotoxins and neurodegenerative disease in Guam. Proc. Natl Acad. Sci. U.S.A. 101, 12228-12231.
35. Murch, S. J., Cox, P. A., Banack, S. A., Steele, J. C., and Sacks, O. W. (2004). Occurrence of beta-methylamino-l-alanine (BMAA) in ALS/PDC patients from Guam. Acta Neurol. Scand. 110, 267-269.
36. Myhrer, T. (2003). Neurotransmitter systems involved in learning and memory in the rat: A meta-analysis based on studies of four behavioral tasks. Brain Res. Brain Res. Rev. 41, 268-287.
37. Olton, D. S., and Papas, B. C. (1979). Spatial memory and hippocampal function. Neuropsychologia 17, 669-682.
38. Pablo, J., Banack, S. A., Cox, P. A., Johnson, T. E., Papapetropoulos, S., Bradley, W. G., Buck, A., and Mash, D. C. (2009). Cyanobacterial neurotoxin BMAA in ALS and Alzheimer's disease. Acta Neurol. Scand. doi:10.1111/j.1600-0404.2008.01150.x.
39. Paerl, H. (2008). Nutrient and other environmental controls of harmful cyanobacterial blooms along the freshwater-marine continuum. Adv. Exp. Med. Biol. 619, 217-237.
40. Paul, V. J. (2008). Global warming and cyanobacterial harmful algal blooms. Adv. Exp. Med. Biol. 619, 239-257.
41. Pryce, C. R., and Feldon, J. (2003). Long-term neurobehavioural impact of the postnatal environment in rats: Manipulations, effects and mediating mechanisms. Neurosci. Biobehav. Rev. 27, 57-71.
42. Rao, S. D., Banack, S. A., Cox, P. A., and Weiss, J. H. (2006). BMAA selectively injures motor neurons via AMPA/kainate receptor activation. Exp. Neurol. 201, 244-252.
43. Roman, E., and Colombo, G. (2009). Lower risk taking and exploratory behavior in alcohol-preferring sP rats than in alcohol non-preferring sNP rats in the multivariate concentric square field (MCSF) test. Behav Brain Res. doi:10.1016/j.bbr.2009.08.020.
44. Roman, E., Gustafsson, L., Berg, M., and Nylander, I. (2006). Behavioral profiles and stress-induced corticosteroid secretion in male Wistar rats subjected to short and prolonged periods of maternal separation. Horm. Behav. 50, 736-747.
45. Roman, E., and Meyerson, B. J. (2009). Assessing incentive approach by a risk/benefit paradigm in the multivariate concentric square field test. In XXXI International Ethological Conference (M. Hausberger, Ed.), p. 388-389. Rennes, France. (abstract).
46. Roman, E., Meyerson, B. J., Hyytia, P., and Nylander, I. (2007). The multivariate concentric square field test reveals different behavioural profiles in male AA and ANA rats with regard to risk taking and environmental reactivity. Behav. Brain Res. 183, 195-205.
47. Ruediger, T., and Bolz, J. (2007). Neurotransmitters and the development of neuronal circuits. Adv. Exp. Med. Biol. 621, 104-115.
48. Saari, M. J., Fong, S., Shivji, A., and Armstrong, J. N. (1990). Enriched housing masks deficits in place navigation induced by neonatal monosodium glutamate. Neurotoxicol. Teratol. 12, 29-32.
49. Snyder, L. R., Cruz-Aguado, R., Sadilek, M., Galasko, D., Shaw, C. A., and Montine, T. J. (2009). Lack of cerebral bmaa in human cerebral cortex. Neurology 72, 1360-1361.
50. Spencer, P. S., Nunn, P. B., Hugon, J., Ludolph, A. C., Ross, S. M., Roy, D. N., and Robertson, R.C. (1987).Guamamyotrophic lateral sclerosis-parkinsonism-dementia linked to a plant excitant neurotoxin. Science 237, 517-522.
51. Steele, J. C., and McGeer, P. L. (2008). The ALS/PDC syndrome of Guam and the cycad hypothesis. Neurology 70, 1984-1990.
52. Viberg, H., Fredriksson, A., and Eriksson, P. (2003). Neonatal exposure to polybrominated diphenyl ether (PBDE 153) disrupts spontaneous behaviour, impairs learning and memory, and decreases hippocampal cholinergic receptors in adult mice. Toxicol. Appl. Pharmacol. 192, 95-106.
53. Zelena, D., Mergl, Z., and Makara, G. B. (2005). Glutamate agonists activate the hypothalamic-pituitary-adrenal axis through hypothalamic paraventricular nucleus but not through vasopressinerg neurons. Brain Res. 1031, 185-193.
54. Zimba, P. V., Khoo, L., Gaunt, P. S., Brittain, S., and Carmichael, W. W. (2001). Confirmation of catfish, Ictalurus punctatus (Rafinesque), mortality from Microcystis toxins. J. Fish Dis. 24, 41-47.